WebOct 3, 2008 · Four-domain soluble CD4 was obtained from Progenics (Tarrytown, NY, USA), and two-domain soluble CD4 was obtained from the National Institutes of Health AIDS Research and Reference Reagent Program. CHO-CCR5 + cells were obtained from Dr. Marc Parmentier (University of Brussels, Brussels, Belgium). WebInternational Science and Engineering Fair 1977. Paul Maddon is a biotechnology entrepreneur who was the founder and is the Retired Chairman of the Board of Progenics Pharmaceuticals, Inc., a publicly traded biopharmaceutical company. He founded Progenics in 1986 while an MD-Ph.D. student at Columbia University and served as Chairman, Chief ...
Item Details - HIVReagentProgram.org
WebThis previously undefined relationship between memory CD4 T cell responses and serological neutralizing capacity in SUDV survivors is key for understanding long lasting immunity in survivors of filovirus infections. ... As CD62L can be cleaved from the cell surface upon T cell activation, we performed an ELISA for soluble CD62L (sCD62L) in the ... WebJul 15, 2002 · High Levels of Antibodies to the CD4 Binding Domain of Human Immunodeficiency Virus Type 1 Glycoprotein 120 Are Associated with Faster Disease Progression The Journal of Infectious Diseases Oxford Academic Abstract. parkade 2 south level 2 or tambo
PROGENICS SOLUBLE CD4 PHASE I STUDIES
WebExamples of PROGENICS in a sentence. No consent or approval of PROGENICS shall be required in connection with the granting of such sublicenses.. BMS shall provide … WebReagent:Human Soluble CD4 Recombinant Protein (sCD4) Catalog Number:4615 Lot Number:120050 Provided:100 µg/vial, 1.0 mg/ml in 50 mM MES, 350 mM NaCl, pH 6.0 Purity:>95% Description: Full-length extracellular domain of human CD4 (amino acids 1-370) produced in a mammalian (CHO) expression system. Special Characteristics: WebAcknowledgment for publications should read “The following reagent was obtained through the NIH HIV Reagent Program, Division of AIDS, NIAID, NIH: Human Soluble CD4 (sCD4) Protein, Recombinant from CHO Cells, ARP-4615, contributed by Progenics Pharmaceuticals, Inc.” Restrictions On Use: ARP-4615 is limited to one aliquot per recipient. parkade 2 cape town international